BNET Industries
Market Cap:$39.6M
Last Fiscal Year Sales:$111.6M
- Public
Dow Jones Description
Nasally-Delivered Over-The-Counter Remedies Developers
Acting President, Chief Financial Officer and Chief Operating Officer
William J. HemeltNumber of Employees 34
Contact Information
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
BRIEF-US appeals court reverses dismissal of Zicam complaint against Matrixx
-
Matrixx Initiatives Inc reports net income down to USD5.1m for fiscal Q2
-
Matrixx Initiatives MTXX Names William J. Hemelt President, CEO and Board Member
-
Matrixx officially names Hemelt as CEO
-
Matrixx Initiatives, Inc. MTXX Names William J. Hemelt President, CEO and Board Member
-
Matrixx 2Q loss widens on recall charge
-
Faruqi & Faruqi, LLP Announces Filing of Class Action Lawsuit Against Matrixx Initiatives, Inc. --...
-
The Eyeshade Smelled Trouble
-
Matrixx Defends Zicam, but Still Recalls It
-
Stocks in the Spotlight Tuesday
News & Analysis
Filter by
matrixx initiatives inc. - All News and Analysis
Matrixx Initiatives, Inc. F2Q10 (Qtr End 09/30/09) Earnings Call Transcript
Question-and-Answer SessionOperator Thank you. Operator Instructions. And we will take our first question from Scott Henry with Roth Capital. Scott Henry – Roth Capital Hello Bill. I guess just starting from the big picture, it seems that this quarter would at least preliminarily indicate that consumers are not afraid...
Matrixx Initiatives Inc. F1Q10 (Qtr End 30/06/09) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Scott Henry - Roth Capital. Scott Henry - Roth Capital I’d start by saying, Bill you might want to lose the acting title as far as the President, certainly given and the working you have in front of you. I...
Matrixx Initiatives Inc. F1Q10 (Qtr End 30/06/09) Earnings Call Transcript
Matrixx Initiatives Inc. MTXX F1Q10 Earnings Call August 11, 2009; 11:00 am ET
Quick Take on Matrixx Initiatives
Steve Alexander submits:Quick Look Date: Aug 7, 2009 Growth: F Competitive Moat: D Management: D Financial Health: A Opinion: Very...
Matrixx Initiatives: A Critical Test of Crisis Management
We have seen a decimation in the shares of Matrixx Intiatives MTXX as a result of the FDA’s June 16th warning letter indicating anosmia experienced in a group of several hundred Zicam nasal product users. Initially Matrixx went into defensive mode, but has since “voluntarily” recalled the Zicam nasal...
Where Was the Press While an Analyst Was Being Crushed by Matrixx Initiatives?
Gary Weiss submits: Gretchen Morgenson had a great column in the New York Times yesterday on the successful effort to crush an independent analyst by Matrixx Initiatives MTXX, the criticism-phobic pharmaceutical company whose OTC cold products were recently ordered recalled by the FDA. Reading her column got...
ZICAM, Banks, and the Illusion of Safety
Ron Rowland submits: By Patrick Watson Two days ago I remarked on the new, improved regulatory structure the Obama administration proposes for the financial services industry. On the same day, the U.S. Food & Drug Administration (FDA) ordered a company called Matrixx Initiatives MTXX to stop selling its popular...
Matrixx Initiatives, Inc., F4Q09 (Qtr End 03/31/09) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Scott Henry from Roth Capital Partners. Scott Henry - Roth Capital Partners LLC Thanks and congratulations on exceeding estimates this year in a very challenging year for the cold/flu season. First, when we look at...
Matrixx Initiatives, Inc., F3Q09 (Qtr Ended 12/31/08) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions. For our first question, we go to Nick Genova with B. Riley and Company. Nick Genova – B. Riley and Company First, on the expense associated with the retirement of the CEO, is that a one-time that is just going to occur...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| William J. Hemelt | Acting President, Chief Financial Officer and Chief Operating Officer |
| Samuel C. Cowley | General Counsel, Secretary & Executive Vice President, Business Dev |
| Anthony Marini James | Vice President Sales |
| James A. Marini | Vice President, Sales |
| Lyan Romero | Vice President, Admin |
| Lynn Romero | Vice President, Admin & Secretary |
| Tim Connors | Vice President, Marketing |
| Timothy L. Clarot | Vice President, R & D |
| Bill Barba | Director, Ir |
| Regina Miskewitz | Director, R & D |
| Dean Kennedy | Controller |
| L. White Matthews | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| William C. Egan | Chair of Board |
| Carl J. Johnson | Board of Directors |
| John M. Clayton | Board of Directors |
| Lori Bush | Board of Directors |
| Matrixx Initiatives | Board of Directors |
| Michael A. Zeher | Board of Directors |
Matrixx is led by Acting President, Chief Financial and Chief Operating Officer William Hemelt, who has more than 20 years of executive management experience. Mr. Hemelt spent more than 17 years with Arizona's largest public utility, Arizona Public Service company, where he held a variety of financial position including six years as treasurer and four years as controller of the company. Mr. Hemelt earned a Master of Business Administration and a Bachelor of Science in Electrical Engineering from Lehigh University. Since joining the company in June 1998, Mr. Hemelt has been instrumental in the development of short and long-term financial strategies designed to support corporate positioning and new product development.
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Acting President, Chief Financial Officer and Chief Operating Officer | Current |
| Arizona Public Service Company | Former |
Formerly with Reckitt & Colman Inc., where he held executive operational and technical positions, Mr. Clarot brings more than 20 years experience to Matrixx, where he oversees all regulatory compliance activities, supply chain management, materials and product development, information technology and consumer affairs. Under his supervision, Matrixx Initiatives, Inc. has designed operational infrastructure to support all phases of development, quality assurance, compliance and supply chain management for the company's Zicam brand product lines, including development of five new products in 2002. Mr. Clarot holds a Bachelor of Science in Chemistry from California State University at Fresno.
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | General Counsel, Secretary & Executive Vice President, Business Dev | Current |
| Matrixx Initiatives, Inc. | Board of Directors | Current |
| SWIFT | Board of Directors | Former |
| Cornell University Law School | B.A. In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Vice President Sales | Current |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Vice President, Sales | Current |
| Mercy College | Former |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Vice President, Admin | Current |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Vice President, Admin & Secretary | Current |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Vice President, Marketing | Current |
| The Pennsylvania State University | Bachelors of Arts Degree In Marketing | Former |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Vice President, R & D | Current |
| California State University | Bachelor of Science In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Director, Ir | Current |
| Matrixx Initiatives, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Director, R & D | Current |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Chair of Board | Current |
| Arm & Hammer Consumer Products | President | Former |
| Personal Care Products, Inc. | Board of Directors | Former |
| Matrixx Initiatives, Inc. | Board of Directors | Former |
| Trinity College | Former |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Board of Directors | Current |
| Matrixx Initiatives, Inc. | President & CEO | Former |
| Wagner College | Bachelors of Science In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Board of Directors | Current |
| Schering-Plough Corporation | Senior Vice President of Scientific and Regulatory Affairs | Former |
| Schering-Plough Healthcare Products Corp. | Senior Vice President of Scientific and Regulatory Affairs | Former |
| Tennessee Technological University | Bachelors of Science In Science, Pharmacy | Former |
L. White Matthews, III, age 63, has been retired since September 2001. From July 1999 until September 2001, Mr. Matthews served as Executive Vice President and Chief Financial Officer of Ecolab, Inc. (a developer and marketer of cleaning and sanitizing products and services) as well as a member of its Board of Directors. Mr. Matthews was retired from May 1998 to July 1999. From February 1977 to May 1998, Mr. Matthews served in various financial positions with Union Pacific Corporation (a company involved in rail/truck transportation and oil/gas exploration and production). From November 1989 to May 1998 he was Executive Vice President and Chief Financial Officer of Union Pacific and he was a member of its Board of Directors from 1994 to 1998. Mr. Matthews has been a director of Imation since February 2003. He is a director of Matrixx Initiatives, Inc., a publicly-held company, and a director of PNC Funds, Inc., a privately-held company.
| Organization | Position | Status |
|---|---|---|
| Imation Corp. | Chair | Current |
| Matrixx Initiatives, Inc. | Director | Current |
| Imation Corp. | Board of Directors | Current |
| Hampden-Sydney College | Bachelor of Science In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Dermaskin Consultants | President and General Manager | Current |
| Rodan Inc. | President | Current |
| Rodan & Fields, LLC. | President and General Manager | Current |
| Nu Skin Enterprises, Inc. | President | Current |
| Helix Biomedix, Inc. | Chief Operating Officer | Current |
| Nu Skin Enterprises, Inc. | Vice President | Current |
| Rodan Inc. | General Manager | Current |
| Matrixx Initiatives, Inc. | Board of Directors | Current |
| Nu Skin Enterprises, Inc. | member | Current |
| Nu Skin, Inc. | President | Former |
| Johnson & Johnson | Vice President of Professional Marketing | Former |
| Nu Skin, Inc. | Vice President of Marketing | Former |
| Neutrogena Corporation | Vice President | Former |
| Johnson & Johnson | Executive Director over Skin Care Ventures | Former |
| Temple University | M.B.A. | Former |
| The Ohio State University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Matrixx Initiatives, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Nutrition 21, Inc. | President, Chief Executive Officer | Current |
| Chromax | President & CEO | Current |
| Chromax | Board of Directors | Current |
| Nutrition 21, Inc. | Board of Directors | Current |
| Matrixx Initiatives, Inc. | Board of Directors | Current |
| International Ltd | Chief Executive Officer | Former |
| Nutritional Laboratories International | Chief Executive Officer | Former |
| Nutritional Laboratories International | President | Former |
| Pharmaceutical Formulations, Inc. | President | Former |
| International Ltd | President | Former |
| Pharmaceutical Formulations, Inc. | Chief Operating Officer | Former |
| Old Dominion University | BS Degree In Business Administration | Former |
Executive News
-
Matrixx Receives SEC Inquiry
| Volume | 113,622 |
| Shares Outstanding | 9.4M |
| Market Cap | 39.6M |
| Year High | 19.74 |
| Year Low | 3.61 |
| Earnings Per Share | -1.11 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes

